Overcoming Biopharmaceutical Interferents for Quantitation of Host Cell DNA Using an Automated, High-Throughput Methodology

The rapid development of biologics and vaccines in response to the current pandemic has highlighted the need for robust platform assays to characterize diverse biopharmaceuticals. A critical aspect of biopharmaceutical development is achieving a highly pure product, especially with respect to residu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauro, Mackenzie L., Bowman, Amy M., Smith, Joseph P., Gaye, Susannah N., Acevedo-Skrip, Jillian, DePhillips, Pete A., Loughney, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735023/
https://www.ncbi.nlm.nih.gov/pubmed/36482268
http://dx.doi.org/10.1208/s12248-022-00764-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735023/
https://www.ncbi.nlm.nih.gov/pubmed/36482268
http://dx.doi.org/10.1208/s12248-022-00764-4

Ejemplares similares